In the present study, we demonstrate that ZNF224 represses c-Myc transcription in CML and coherently hampers c-Myc proliferative network, reducing CML cells proliferation and DNA synthesis. Here, ZNF224 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.